Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Dr. Hönle AG's (ETR:HNL) top owners are individual investors with 60% stake, while 20% is held by institutions

Key Insights

  • The considerable ownership by individual investors in Dr. Hönle indicates that they collectively have a greater say in management and business strategy

  • A total of 21 investors have a majority stake in the company with 40% ownership

  • 20% of Dr. Hönle is held by Institutions

A look at the shareholders of Dr. Hönle AG (ETR:HNL) can tell us which group is most powerful. With 60% stake, individual investors possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Institutions, on the other hand, account for 20% of the company's stockholders. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders.

In the chart below, we zoom in on the different ownership groups of Dr. Hönle.

View our latest analysis for Dr. Hönle

ownership-breakdown
XTRA:HNL Ownership Breakdown September 1st 2023

What Does The Institutional Ownership Tell Us About Dr. Hönle?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

We can see that Dr. Hönle does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Dr. Hönle's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
XTRA:HNL Earnings and Revenue Growth September 1st 2023

We note that hedge funds don't have a meaningful investment in Dr. Hönle. Zweiunddreisigste PMB Management GmbH is currently the company's largest shareholder with 20% of shares outstanding. With 6.3% and 3.4% of the shares outstanding respectively, Teslin Capital Management BV and Lazard Frères Gestion SAS are the second and third largest shareholders.

Our studies suggest that the top 21 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage.